Longeveron Management
Management criteria checks 0/4
Longeveron's CEO is Mohamed Wa'el Hashad, appointed in Feb 2023, has a tenure of 1.92 years. total yearly compensation is $1.66M, comprised of 25.9% salary and 74.1% bonuses, including company stock and options. directly owns 1.8% of the company’s shares, worth $484.06K. The average tenure of the management team and the board of directors is 1.5 years and 2.6 years respectively.
Key information
Mohamed Wa'el Hashad
Chief executive officer
US$1.7m
Total compensation
CEO salary percentage | 25.9% |
CEO tenure | 1.9yrs |
CEO ownership | 1.8% |
Management average tenure | 1.5yrs |
Board average tenure | 2.6yrs |
Recent management updates
Recent updates
Will Longeveron (NASDAQ:LGVN) Spend Its Cash Wisely?
Nov 17Longeveron Inc.: A New Approach To Treat Alzheimer's
Oct 09Longeveron spikes after FDA’s Fast Track Designation for lead candidate
Aug 31Is Longeveron (NASDAQ:LGVN) In A Good Position To Invest In Growth?
Jul 15Longeveron rises ~20%, co to present Alzheimer's trial abstract at leading conference
Jul 07CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$27m |
Jun 30 2024 | n/a | n/a | -US$28m |
Mar 31 2024 | n/a | n/a | -US$22m |
Dec 31 2023 | US$2m | US$431k | -US$22m |
Compensation vs Market: Mohamed Wa'el's total compensation ($USD1.66M) is above average for companies of similar size in the US market ($USD645.01K).
Compensation vs Earnings: Insufficient data to compare Mohamed Wa'el's compensation with company performance.
CEO
Mohamed Wa'el Hashad (62 yo)
1.9yrs
Tenure
US$1,662,854
Compensation
Mr. Mohamed Wa'el Ahmed Hashad, M.B.A. has been Chief Executive Officer at Longeveron Inc. since February 2023 and also has been its Director since June 09, 2023. Mr. Hashad had been Independent Director a...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 11yrs | US$87.13k | 8.02% $ 2.2m | |
CEO & Director | 1.9yrs | US$1.66m | 1.8% $ 484.1k | |
CFO & Treasurer | 1.5yrs | US$604.67k | 1.03% $ 275.5k | |
International Executive Director | no data | US$554.06k | 1.07% $ 286.6k | |
Chief Technology Officer & Senior Vice President of Chemistry | less than a year | no data | no data | |
Senior Vice President of Strategic Collaborations & Scientific Affairs | 3.7yrs | no data | no data | |
Chief Medical Officer | 1.5yrs | no data | 1.02% $ 274.6k | |
Vice President of Manufacturing | no data | no data | no data | |
VP of Research & Discovery | no data | no data | no data | |
VP & Corporate Controller | less than a year | no data | no data | |
VP & Corporate Controller | less than a year | no data | no data | |
VP & Corporate Controller | less than a year | no data | no data |
1.5yrs
Average Tenure
55.5yo
Average Age
Experienced Management: LGVN's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 11yrs | US$87.13k | 8.02% $ 2.2m | |
CEO & Director | 1.6yrs | US$1.66m | 1.8% $ 484.1k | |
Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 1.6yrs | US$47.78k | 0.16% $ 43.0k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Director | 9.3yrs | US$52.13k | 2.06% $ 552.5k | |
Director | 4.8yrs | US$55.63k | 1.41% $ 377.4k | |
Independent Director | 3.6yrs | US$62.63k | 0.0034% $ 905.0 |
2.6yrs
Average Tenure
61.5yo
Average Age
Experienced Board: LGVN's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/10 10:13 |
End of Day Share Price | 2025/01/08 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Longeveron Inc. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Raghuram Selvaraju | H.C. Wainwright & Co. |
Boobalan Pachaiyappan | H.C. Wainwright & Co. |
Jason McCarthy | Maxim Group |